RAXONE

Welcome to the Brand page for “RAXONE”, which is offered here for Pharmaceutical, veterinary and sanitary preparations, chemical preparations for use in the treatment of muscular dystrophy, muscle wasting, atrophy, neuromuscular diseases, cardiomyopathies, ataxias, optic nerve degradation, neurological indications and memory loss;chemicals used in industry and science;computer programming for scientific and industrial research in the fields of cell cultures, muscular dystrophy, muscle wasting, atrophy, neuromuscular diseases, cardiomyopathies, ataxias, optic nerve degradation, neurological indications and memory loss; scientific re-search for cellular test systems that evaluate drugs and antibodies; scientific research for finding pharmacologically active compounds and animal models for neuromuscular diseases, scientific research in the fields of muscular dystrophy, muscle wasting, atrophy, neuromuscular diseases, cardiomyopathies, ataxias, optic nerve degradation, neurological indications and memory loss;.

Its status is currently believed to be active. Its class is unavailable. “RAXONE” is believed to be currently owned by “Santhera Pharmaceuticals (Schweiz) AG”.